HARDY ALEXANDER (Chief Executive Officer) received a stock award from BIOMARIN PHARMACEUTICAL INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/17/2026ACC: 0001628280-26-019006
DirectorOfficer· Chief Executive Officer
Since Dec 2023
+148.70K
Net shares
Net buyer
$172.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
151.64K acquired · 2.94K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.94K
Price / share
$58.51
Trade value
$172.08K
% of position
1.8%
3/13/2026
159.39K→156.45K
Common Stock
Direct
Shares
+62.44K
Price / share
—
Trade value
—
% of position
39.9%
3/16/2026
156.45K→218.89K
Total
Net shares
+59.50K
Net value
-$172.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2026 | F · Tax Withholding | −2.94K | $58.51 | $172.08K | 1.8% | 159.39K | 156.45K |
| Common Stock Direct | 3/16/2026 | A · Award | +62.44K | — | — | 39.9% | 156.45K | 218.89K |
| Total | +59.50K | -$172.08K | ||||||
Derivative Transactions1
Stock Option (Right to Buy Common Stock)
Direct
Converts to
Common Stock
89.20K shares
Shares
+89.20K
Strike price
57.43
Held after
89.20K
Exercisable
—
3/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock) Direct | Common Stock89.20K shares | 3/16/2026 | A · Award | +89.20K | 57.43 | — | 89.20K |